Wayland Announces Significant Supply Agreement with RavenQuest BioMed
December 18, 2018
TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in... Read more
Biome Grow Receives New Consumer Sales Amendment From Health Canada For Its Nova Scotia brand, Highland Grow.
December 17, 2018
Ryan Allway December 17th, 2018 News, Top News Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets Toronto, Ontario (December 17th, 2018) – Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to... Read more
Yield Growth Appoints Former COO and CFO of MAC Cosmetics Thomas Bond as Director of Yield & Chairman of the Board, Urban Juve
December 17, 2018
Ryan Allway December 17th, 2018 News, Top News VANCOUVER, British Columbia, Dec. 17, 2018 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS, C.BOSS), is pleased to announce that it has appointed Mr. Thomas Bond to the Yield Growth Board of Directors and appointed him as Chairman of the... Read more
Chemesis International Inc. Acquires Viverian CBD Product Catalogue
December 17, 2018
Ryan Allway December 17th, 2018 News, Top News VANCOUVER, British Columbia, Dec. 17, 2018 (GLOBE NEWSWIRE) — Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it has acquired Viverian, a hemp-derived CBD product line that promotes healthy living and provides consumers with... Read more
FSD Pharma Congratulates High Tide for Its Listing and Commencement of Trading on the CSE
December 17, 2018
Ryan Allway December 17th, 2018 News, Top News FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTCQB:FSDDF) (FRA:0K9) would like to congratulate High Tide Inc. (“High Tide”) for its listing approval and commencement of trading on the Canadian Securities Exchange (“CSE”) today under the stock symbol “HITI”. FSD... Read more
Cannabis Users Drive High, and Crashes Are on the Rise
December 14, 2018
Robin Lefferts December 14th, 2018 Exclusive, Top Story As cannabis legalization spreads across North America, there is a growing realization of the public safety issues surrounding widespread use of the legalized drug. Even cannabis consumers admit that driving under the influence of marijuana can be dangerous, but in... Read more
Yield Growth Shares Commence Trading on the CSE Under Symbol “BOSS”
December 14, 2018
Ryan Allway December 14th, 2018 News, Top News VANCOUVER, B.C., Dec. 14, 2018 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS, C.BOSS), announces its shares commenced trading on the Canadian Securities Exchange under the symbol BOSS. At the same time, Yield Growth President and CEO Penny Green announces the... Read more
Chemesis International Inc. Announces Second Tranche of Convertible Debenture Offering
December 14, 2018
VANCOUVER, British Columbia, Dec. 13, 2018 (GLOBE NEWSWIRE) — Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is pleased to announce that it intends to complete a second tranche private placement financing of convertible debentures (“Convertible Debentures”) (see news release dated December 5, 2018 with respect... Read more
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
December 14, 2018
Ryan Allway December 14th, 2018 Exclusive, Top News The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s... Read more
Blockchain Technology Offers a Solution to Cannabis Quality Control
December 14, 2018
Ryan Allway December 14th, 2018 Exclusive, News, Top News The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, following the legalization of adult-use cannabis earlier this year. While early sales have been brisk, the industry faces key challenges with safety... Read more
